Directori

GARCÍA PRAS, Ester

Departament de Ciències Bàsiques

GARCÍA PRAS, Ester

CV

Perfil del professor

Ciències Bàsiques, DEPARTAMENT DE CIÈNCIES BÀSIQUES. Universitat Internacional de Catalunya

Formació acadèmica

Doctora en Medicina i Recerca Traslacional, Universitat de Barcelona
Màster Universitari en Recerca de Malalties Hepàtiques, Universitat de Barcelona
Llicenciada en Biologia, Universitat de Barcelona

Experiència professional

Investigadora Postdoctoral Laboratorio Hepatitis Víricas, Tóxicas y Metabólicas / Institut d`Investigacions Biomèdiques August Pi i Sunyer, CIBER ENFERMEDADES HEPATICAS Y DIGESTIVAS (CIBEREHD)

Publicacions
- Garcia-Lopez M; Lens S; J Pallet, L; et al; Perez del Pulgar, S. 2020. Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients Journal of Hepatology. 20-S0168, pp.33830-33837.
- Garcia-Pras, E; Gallego,J; Fernandez, M. 2017. Therapeutic siRNA targeting endothelial KDR decreases portosystemic collateralization in portal hypertension Scientific Reports. Nature.
- Garcia Pras, E.; Gallego, J.; Coch, L.; et al; Fernandez, M.(1/9). 2017. Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension.Gut. 66-7, pp.1306-1320. ISSN 1468-3288.
- Mercedes Fernández Lobato; Marc Mejías Hernández; Ester Garcia Pras; Javier Gallego Pinos; Núria Pell; Marta Ramirez Pedraza; Salvador Naranjo Suarez; Alba Barrachina Català. 2016. Pathogenesis of portal hypertension: Extrahepatic mechanisms Current Hepatology Reports. 15-3, pp.199-207.
- Calderone, V*; Gallego, J*; Fernandez Miranda, G.; et al; Mendez, R.2016. Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.Gastroenterology. 150-4, pp.982. ISSN 1528-0012.
- Mejias, M.; Coch, L.; Berzigotti, A.; Garcia Pras, E.; Gallego, J.; Bosch, J.; Fernandez, M.2015. Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats.Gut. 64-4, pp.657-723. ISSN 1468-3288.
- Coch, L.; Mejias, M.; Berzigotti, A.; Garcia Pras, E.; Gallego, J.; Bosch, J.; Mendez, R.; Fernandez, M.2014. Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.Hepatology (Baltimore, Md.). 60-2, pp.633-680. ISSN 1527-3350.
- D'Amico, M.; Mejías, M.; García Pras, E.; Abraldes, JG.; García Pagán, JC.; Fernández, M.; Bosch, J.2012. Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.American journal of physiology. Gastrointestinal and liver physiology. 302-10, pp.G1191. ISSN 1522-1547.
- Mejias, M.; Garcia Pras, E.; Gallego, J.; Mendez, R.; Bosch, J.; Fernandez, M.2010. Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension.Journal of hepatology. 52-4, pp.529-568. ISSN 1600-0641.
- Batlle, M.; Pérez Villa, F.; Lázaro, A.; García Pras, E.; Vallejos, I.; Sionis, A.; Castel, MA.; Roig, E.2009. Decreased expression of thrombospondin-1 in failing hearts may favor ventricular remodeling.Transplantation proceedings. 41-6, pp.2231-2234. ISSN 1873-2623.
- Mejias, M.; Garcia Pras, E.; Tiani, C.; Miquel, R.; Bosch, J.; Fernandez, M.2009. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.Hepatology (Baltimore, Md.). 49-4, pp.1245-1301. ISSN 1527-3350.
- Tiani, C.; Garcia Pras, E.; Mejias, M.; de Gottardi, A.; Berzigotti, A.; Bosch, J.; Fernandez, M.2009. Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension.Journal of hepatology. 50-2, pp.296-601. ISSN 0168-8278.
- Mejias, M.; Garcia Pras, E.; Tiani, C.; Bosch, J.; Fernandez, M.2008. The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.Journal of cellular and molecular medicine. 12-5A, pp.1690-1699. ISSN 1582-1838.
- Mercedes Fernández Lobato; Marc Mejías Hernández; Ester Garcia Pras; Jaume Bosch Genover. 2008. Role of angiogenesis in portal hypertension Proceedings of the II Falk Gastro-Conference. pp.112-129.
- Fernandez, M.; Mejias, M.; Garcia Pras, E.; Mendez, R.; Garcia Pagan, JC.; Bosch, J.2007. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.Hepatology (Baltimore, Md.). 46-4, pp.1208-1225. ISSN 0270-9139.
- Batlle, M.; Pérez Villa, F.; Lázaro, A.; et al; Roig, E.2007. Correlation between mast cell density and myocardial fibrosis in congestive heart failure patients.Transplantation proceedings. 39-7, pp.2347-2356. ISSN 0041-1345.
- Batlle, M.; Pérez Villa, F.; García Pras, E.; Lázaro, A.; Orús, J.; Roqué, M.; Roig, E.2007. Down-regulation of matrix metalloproteinase-9 (MMP-9) expression in the myocardium of congestive heart failure patients.Transplantation proceedings. 39-7, pp.2344-2350. ISSN 0041-1345.
- Batlle, M.; Roig, E.; Perez Villa, F.; et al; Jimenez, W.2006. Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 25-9, pp.1117-1142. ISSN 1557-3117.